Mefloquine Mefloquine Mefloquine, sold under the brand names Lariam among others, is a medication used to prevent or treat malaria. When used for prevention it is taken once a week and should be started one or two weeks before potential exposure and continued for four weeks after potential exposure. It can be used to treat mild or moderate malaria but should not be used to treat severe malaria. It is taken by mouth. Serious side effects include potentially long-term mental health problems such as depression, hallucinations, and anxiety and neurological side effects such as poor balance, seizures, and ringing in the
Association for the Treatment of Sexual Abusers 2.926, ranking 5th out of the 58 tracked journals in criminology and penology. The journal typically receives 100-150 manuscript submissions annually from researchers and practitioners in 25-30 countries and has an acceptance rate of approximately 50 percent. Association for the Treatment of Sexual Abusers The Association for the Treatment of Sexual Abusers (ATSA) is an international, multi-disciplinary, non-profit organization dedicated to making society safer by preventing sexual abuse. ATSA promotes sound research, evidence-based practice, informed public policy, and collaborative community strategies that lead to the effective assessment, treatment, and management of individuals who sexually abuse or are at risk to